S16 Ep11: Expert Illustrations & Commentaries: Translating the Science of Bispecific Antibodies in Solid Tumors – From Mechanisms to Emerging Data
OncLive® On Air
00:00
Harmony 2: Ivanesimab vs Pembrolizumab
John V. Heymach reviews Harmony 2 results showing a marked PFS advantage and manageable VEGF-related toxicities.
Play episode from 16:32
Transcript
